Development of a single item patient reported measure of treatment side effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement

By afschroeder • June 28, 2026

Berthelsen DB, Horgan B, Simon L, Ioannidis JPA, Goel N, Tugwell P, Balay-Dustrude E, Bartlett SJ, Bingham CO, Boers M, Bouillot C, Böhm P, Choy E, Cowern M, Dagsvik K, Djurtoft C, Furst DE, Haugegaard T, Hazlewood GS, Hoens AM, Jørgensen TS, Kelly SE, Kruzikas D, Musaus J, Richards P, Shea BJ, Strand V, Thomas M, Torralba K, Voshaar M, Weinbrecht-Mischkewitz M, Woodworth TG, Wright G, Flurey C, Christensen R; OMERACT Safety Working Group. Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement. Semin Arthritis Rheum. 2026 Jun 19;79:153026. doi: 10.1016/j.semarthrit.2026.153026. Epub ahead of print. PMID: 42364594.

Tags: Adverse events, Core outcome set, Harms, Large language model, OMERACT, Publications, Rheumatology, rheumatology, safety

Training Stage, Program Pedigree, Degree Pathway, and Research Productivity among United States Gastroenterology Fellows

Stirrat TS, Tian T, Solanky P, Apte S, Shahrin S, Flatley M, Thiru S, Kakde S, Kanth P. Training Stage, Program Pedigree, Degree Pathway, and[...]

Response by Fonarow et al to Letter Regarding Article, “Improving Heart Failure Quality of are Over the First Twenty Years: The Get With The Guidelines-Heart Failure Program”

Tang AB, Greene SJ, Fonarow GC. Response by Fonarow et al to Letter Regarding Article, "Improving Heart Failure Quality of are Over the First Twenty[...]

Silicosis in the Artificial Stone Countertop Industry: An Official American Thoracic Society Workshop Report

Gandhi SA, Liu GY, Fazio JC, Amubieya O, Barnes H, Cavalin C, Cohen RA, Fireman E, Garcia SR, Harrison RJ, Houlroyd JL, Hua JT, Jones[...]